Transcend Capital Advisors, LLC Merck & Co., Inc. Transaction History

Transcend Capital Advisors, LLC

$1.44 Billion
Q3 2024

A detailed history of Transcend Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 294,059 shares of MRK stock, worth $28.8 Million. This represents 2.31% of its overall portfolio holdings.

Number of Shares

294,059

Previous 298,551 1.5%

Holding current value

$28.8 Million

Previous $37 Million 9.65%

% of portfolio

2.31%

Previous 2.74%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$111.15 - $128.97 $499,285 - $579,333	-4,492 Reduced 1.5%	294,059 $33.4 Million
Q2 2024 Jul 02, 2024	BUY	$123.8 - $132.96 $507,827 - $545,401	4,102 Added 1.39%	298,551 $37 Million
Q1 2024 May 03, 2024	BUY	$113.24 - $131.95 $379,920 - $442,692	3,355 Added 1.15%	294,449 $38.9 Million
Q4 2023 Feb 05, 2024	BUY	$100.18 - $109.02 $47,585 - $51,784	475 Added 0.16%	291,094 $31.7 Million
Q3 2023 Oct 31, 2023	SELL	$102.95 - $114.33 $148,145 - $164,520	-1,439 Reduced 0.49%	290,619 $29.9 Million
Q2 2023 Jul 13, 2023	BUY	$108.61 - $118.38 $240,245 - $261,856	2,212 Added 0.76%	292,058 $33.7 Million
Q1 2023 Apr 12, 2023	SELL	$102.94 - $114.86 $439,862 - $490,796	-4,273 Reduced 1.45%	289,846 $30.8 Million
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $253,488 - $325,006	-2,899 Reduced 0.98%	294,119 $0
Q3 2022 Oct 17, 2022	BUY	$84.53 - $94.96 $68,638 - $77,107	812 Added 0.27%	297,018 $25.6 Million
Q2 2022 Jul 12, 2022	BUY	$83.49 - $94.64 $16,781 - $19,022	201 Added 0.07%	296,206 $27 Million
Q1 2022 Apr 20, 2022	SELL	$73.51 - $82.4 $840,807 - $942,491	-11,438 Reduced 3.72%	296,005 $24.3 Million
Q4 2021 Jan 20, 2022	BUY	$72.28 - $90.54 $150,848 - $188,956	2,087 Added 0.68%	307,443 $23.6 Million
Q3 2021 Nov 04, 2021	BUY	$71.68 - $78.83 $21.9 Million - $24.1 Million	305,356 New	305,356 $25.1 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $21.8 Million - $24.1 Million	-310,505 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$68.86 - $81.11 $53,435 - $62,941	776 Added 0.25%	310,505 $23.9 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $1.15 Million - $1.28 Million	16,022 Added 5.46%	309,729 $25.3 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $872,671 - $989,178	11,925 Added 4.23%	293,707 $24.4 Million
Q2 2020 Aug 05, 2020	SELL	$70.42 - $80.13 $291,750 - $331,978	-4,143 Reduced 1.45%	281,782 $21.8 Million
Q1 2020 May 08, 2020	BUY	$63.36 - $87.82 $77,679 - $107,667	1,226 Added 0.43%	285,925 $22 Million
Q4 2019 Feb 19, 2020	BUY	$77.58 - $87.54 $22.1 Million - $24.9 Million	284,699 New	284,699 $25.9 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.

Account

Transcend Capital Advisors, LLC Merck & Co., Inc. Transaction History